Prebiotics Feeds gut bacteria that keep GLP-1 levels steady all day
Retatrutide, a triple agonist targeting GLP-1, GIP, and glucagon receptors simultaneously, represents the frontier of this drug class
Oxidative pathways in the sickle cell and beyond
It has shown promise against autoimmune and chronic disease processes
8-year trends in obesity, type 2 diabetes, and glucagon-like peptide-1 (GLP-1) use in patients with obstructive sleep apnea
Additionally, to verify the efficacy of CPP-CAND in triggering cancer cell senescence induced by other anticancer drugs, we tested its effects on senescent cancer cells induced by cisplatin (CDDP)